About LIM homeobox transcription factor 1-alpha
LIM homeobox transcription factor 1-alpha (LMX1A) is a protein
from Homo sapiens identified by UniProt accession
Q8TE12, 382 residues long.
MolForge cross-references it against 0 known binders and
292 disease associations.
Target properties
| Protein name | LIM homeobox transcription factor 1-alpha |
| UniProt accession | Q8TE12 |
| Gene | LMX1A |
| Organism | Homo sapiens |
| Length | 382 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (292)
Diseases linked to this target (Open Targets).
- autosomal dominant nonsyndromic hearing loss 7 · score 0.67
- autosomal dominant nonsyndromic hearing loss · score 0.51
- BMI-adjusted waist-hip ratio · score 0.39
- alcohol consumption measurement · score 0.35
- mathematical ability · score 0.34
- neurodegenerative disease · score 0.34
- Sensorineural hearing impairment · score 0.33
- sensorineural hearing loss · score 0.33
- brain measurement · score 0.31
- cortical thickness · score 0.31
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TE12-F1 | alphafold | PREDICTED | 68.59 | — |
Amino-acid sequence (382 residues)
MLDGLKMEEN FQSAIDTSAS FSSLLGRAVS PKSVCEGCQR VILDRFLLRL NDSFWHEQCV QCASCKEPLE TTCFYRDKKL YCKYDYEKLF AVKCGGCFEA IAPNEFVMRA QKSVYHLSCF CCCVCERQLQ KGDEFVLKEG QLLCKGDYEK ERELLSLVSP AASDSGKSDD EESLCKSAHG AGKGTAEEGK DHKRPKRPRT ILTTQQRRAF KASFEVSSKP CRKVRETLAA ETGLSVRVVQ VWFQNQRAKM KKLARRQQQQ QQDQQNTQRL SSAQTNGGGS AGMEGIMNPY TALPTPQQLL AIEQSVYSSD PFRQGLTPPQ MPGDHMHPYG AEPLFHDLDS DDTSLSNLGD CFLATSEAGP LQSRVGNPID HLYSMQNSYF TS
Explore LIM homeobox transcription factor 1-alpha with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets